Many studies have revealed the capacity of EPB41 to predict the prognosis of various cancers and its critical role in the development of tumours, such as breast cancer [44], meningiomas [45], prostate cancer [46], and hepatocellular carcinoma [47]. The gene discussed is EPB41; the disease is prostate carcinoma.